Fig. 3.
Fig. 3. Human hematopoietic and nonhematopoietic cell lines adhere to mouse or human ICAM-4 with similar avidity. / Adhesion to mouse and human ICAM-4 is mediated by α4β1 integrin on hematopoietic cells and by αV integrins on nonhematopoietic cells. (A) Adhesion of Mn2+-activated HEL cells to mouse (m) or human (h) ICAM-4–Fc or NCAM-Fc control protein. The results are the percentage of total input cells bound ±SD (n = 3). Dilution analysis was performed and the concentrations of protein applied to microplate wells are indicated as abscissa. (B) Adhesion of Mn2+-activated HEL cells to mouse or human ICAM-4–Fc or NCAM-Fc control protein in the presence of function-blocking antibodies against integrin α or β subunits. The fusion proteins were applied at a concentration of 10 μg/mL. Results are shown as the percentage of total input cells bound relative to binding to control antibody ±SD (n = 6). Adhesion in the presence of mouse IgG1 (C1) or rat IgG (C2) control antibodies is shown as 100% (actual values obtained were in the range of 42%-50% or 55%-60% adhesion of input cells to human or mouse ICAM-4–Fc, respectively). Percent adhesion in the presence of mouse antibodies against α2, α4, α5 or β3, or rat antibodies against β1 or αV subunits is shown. N indicates percent adhesion to NCAM-Fc control protein in the absence of antibody. (C) Adhesion of PMA+Mn2+-activated FLY cells to mouse (m) or human (h) ICAM-4–Fc or NCAM-Fc control protein. The results are the percentage of total input cells bound ±SD (n = 3). Concentrations of protein applied to microplate wells are indicated as abscissa. (D) Adhesion of PMA+Mn2+-activated FLY cells to mouse or human ICAM-4–Fc or NCAM-Fc control protein in the presence of function-blocking antibodies against integrin α or β subunits. Fusion proteins were applied at a concentration of 10 μg/mL. Results are shown as the percentage of total input cells bound relative to binding to control antibody ±SD (n = 6). Adhesion in the presence of mouse IgG1 (C1) or rat IgG (C2) control antibodies is shown as 100% (actual values obtained were in the range of 65%-75% or 76%-80% adhesion of input cells to human or mouse ICAM-4–Fc, respectively). Percent adhesion in the presence of mouse antibodies against αVβ5 integrin complex, α4subunit or rat antibodies against β1, αV, or α6 subunits is shown. N indicates percent adhesion to NCAM-Fc control protein in the absence of antibody.

Human hematopoietic and nonhematopoietic cell lines adhere to mouse or human ICAM-4 with similar avidity.

Adhesion to mouse and human ICAM-4 is mediated by α4β1 integrin on hematopoietic cells and by αV integrins on nonhematopoietic cells. (A) Adhesion of Mn2+-activated HEL cells to mouse (m) or human (h) ICAM-4–Fc or NCAM-Fc control protein. The results are the percentage of total input cells bound ±SD (n = 3). Dilution analysis was performed and the concentrations of protein applied to microplate wells are indicated as abscissa. (B) Adhesion of Mn2+-activated HEL cells to mouse or human ICAM-4–Fc or NCAM-Fc control protein in the presence of function-blocking antibodies against integrin α or β subunits. The fusion proteins were applied at a concentration of 10 μg/mL. Results are shown as the percentage of total input cells bound relative to binding to control antibody ±SD (n = 6). Adhesion in the presence of mouse IgG1 (C1) or rat IgG (C2) control antibodies is shown as 100% (actual values obtained were in the range of 42%-50% or 55%-60% adhesion of input cells to human or mouse ICAM-4–Fc, respectively). Percent adhesion in the presence of mouse antibodies against α2, α4, α5 or β3, or rat antibodies against β1 or αV subunits is shown. N indicates percent adhesion to NCAM-Fc control protein in the absence of antibody. (C) Adhesion of PMA+Mn2+-activated FLY cells to mouse (m) or human (h) ICAM-4–Fc or NCAM-Fc control protein. The results are the percentage of total input cells bound ±SD (n = 3). Concentrations of protein applied to microplate wells are indicated as abscissa. (D) Adhesion of PMA+Mn2+-activated FLY cells to mouse or human ICAM-4–Fc or NCAM-Fc control protein in the presence of function-blocking antibodies against integrin α or β subunits. Fusion proteins were applied at a concentration of 10 μg/mL. Results are shown as the percentage of total input cells bound relative to binding to control antibody ±SD (n = 6). Adhesion in the presence of mouse IgG1 (C1) or rat IgG (C2) control antibodies is shown as 100% (actual values obtained were in the range of 65%-75% or 76%-80% adhesion of input cells to human or mouse ICAM-4–Fc, respectively). Percent adhesion in the presence of mouse antibodies against αVβ5 integrin complex, α4subunit or rat antibodies against β1, αV, or α6 subunits is shown. N indicates percent adhesion to NCAM-Fc control protein in the absence of antibody.

Close Modal

or Create an Account

Close Modal
Close Modal